Pfizer Inc. (BKK:PFIZER19)

Thailand flag Thailand · Delayed Price · Currency is THB
15.20
-0.40 (-2.56%)
At close: Aug 1, 2025, 4:30 PM ICT
-2.56%
Market Cap4.34T
Revenue (ttm)2.12T
Net Income (ttm)267.27B
Shares Outn/a
EPS (ttm)46.90
PE Ratio16.25
Forward PE8.36
Dividend0.24 (1.56%)
Ex-Dividend DateJul 25, 2025
Volume107,368
Average Volume77,177
Open15.60
Previous Close15.60
Day's Range15.20 - 15.70
52-Week Range15.00 - 17.00
Betan/a
RSI34.71
Earnings DateAug 5, 2025

About United States Steel

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange Stock Exchange of Thailand
Ticker Symbol PFIZER19
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial Statements

News

There is no news available yet.